Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Three patients affected by Behçet’s disease (BD) with severe uveitis and neurological involvement in stable clinical remission and who rapidly relapsed after switching from reference infliximab (re-IFX) to biosimilar infliximab (bio-IFX) are reported. In order to observe the rules of local health au...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Rheumatol
Main Authors: Cantini, Fabrizio, Niccoli, Laura, Nannini, Carlotta, Cassarà, Emanuele, Kaloudi, Olga
Formato: Artigo
Idioma:Inglês
Publicado em: Medical Research and Education Association 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741345/
https://ncbi.nlm.nih.gov/pubmed/29308287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados